GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nutriband Inc (FRA:9WV) » Definitions » Additional Paid-In Capital

Nutriband (FRA:9WV) Additional Paid-In Capital : €40.32 Mil(As of Apr. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Nutriband Additional Paid-In Capital?


Nutriband's quarterly additional paid-in capital increased from Oct. 2023 (€30.15 Mil) to Jan. 2024 (€31.62 Mil) and increased from Jan. 2024 (€31.62 Mil) to Apr. 2024 (€40.32 Mil).

Nutriband's annual additional paid-in capital increased from Jan. 2022 (€26.49 Mil) to Jan. 2023 (€28.85 Mil) and increased from Jan. 2023 (€28.85 Mil) to Jan. 2024 (€31.62 Mil).


Nutriband Additional Paid-In Capital Historical Data

The historical data trend for Nutriband's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nutriband Additional Paid-In Capital Chart

Nutriband Annual Data
Trend Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only 8.18 15.49 26.49 28.85 31.62

Nutriband Quarterly Data
Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 28.51 28.26 30.15 31.62 40.32

Nutriband Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Nutriband Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Nutriband's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Nutriband (FRA:9WV) Business Description

Industry
Traded in Other Exchanges
Address
121 South Orange Avenue, Suite 1500, Orlando, FL, USA, 32801
Nutriband Inc is primarily engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's lead product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.

Nutriband (FRA:9WV) Headlines

No Headlines